PROST Project final results are online in this article:
Toward autonomous robotic prostate biopsy: a pilot study.
With Bogdan Maris, Chiara Tenga, Rudy Vicario, Luigi Palladino, Noè Murr, Michela De Piccoli, Andrea Calanca, Stefano Puliatti, Salvatore Micali, Alessandro Tafuri and Paolo Fiorini.
Prostate cancer is the second most common cancer, after breast cancer, and is one of the leading causes of death in men.
PROST is our first #prototype of a prostate biopsy robot that includes a level of autonomy in target identification, image fusion and needle guidance
The robot aims at reducing human error in #biopsy planning and execution, it can also guarantee that high-accuracy prostate biopsies are accessible, thanks to a low-cost solution that works independently of the clinician’s experience.
Our pre-clinical ex-vivo #tests were performed in collaboration with a cohort of 10 urologists from the Università degli Studi di Verona #AOUI Azienda Ospedaliera Universitaria Integrata Verona and Università degli Studi di Modena e Reggio Emilia.
PROST is funded by the European Research Council under the Proof of Concept grant.
About Prost
Prostate cancer is the second most common cancer, after breast cancer, and is one of the leading causes of death in men.
PROST is our first #prototype of a prostate biopsy robot that includes a level of autonomy in target identification, image fusion and needle guidance
The robot aims at reducing human error in #biopsy planning and execution, it can also guarantee that high-accuracy prostate biopsies are accessible, thanks to a low-cost solution that works independently of the clinician’s experience.
Our pre-clinical ex-vivo #tests were performed in collaboration with a cohort of 10 urologists from the Università degli Studi di Verona #AOUI Azienda Ospedaliera Universitaria Integrata Verona and Università degli Studi di Modena e Reggio Emilia.
PROST is funded by the European Research Council under the Proof of Concept grant.